DJIA 17,678.70 6.10 0.03%
NASDAQ 4,771.76 13.88 0.29%
S&P 500 2,057.09 5.27 0.26%
market minute promo

Biogen Idec (NASDAQ: BIIB)

362.44 4.91 (1.37%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BIIB $362.44 1.37%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $357.63
Previous Close $357.53
Daily Range $355.45 - $362.84
52-Week Range $272.02 - $366.17
Market Cap $85.6B
P/E Ratio 33.86
Dividend (Yield) $0.00 (0.0%)
Volume 1,330,385
Average Daily Volume 1,828,677
Current FY EPS $13.47

Sector

Healthcare

Industry

Drugs

Biogen Idec (BIIB) Description

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website: http://www.biogenidec.com/

News & Commentary

State of the Union Address Investing Idea: Precision Medicine

There are plenty of companies developing precision medicine drugs already, and investors would be wise to watch key players.

How Will M&A ETFs Perform In 2015? Many Deals Lined Up

5 Big Biotech Earnings Releases To Watch This Week

Commit To Purchase Biogen Idec At $240, Earn 6.7% Using Options

Zillow Is In Limbo - Cramer's Lightning Round (1/23/15)

'Mad Money' Lightning Round: Constellation Brands the New King in Town

3 Stocks Dragging The Health Care Sector Downward

Biotech Stock Roundup: EU Approvals for AbbVie & Celgene Drugs, CytRx Partial Clinical Hold Lifted -

Biotech Stock Roundup: EU Approvals for AbbVie & Celgene Drugs, CytRx Partial Clinical Hold Lifted - Analyst Blog

'Mad Money' Lightning Round: I Want You to Own Perrigo

The 5 Biggest Biotech Stocks

See More BIIB News...

BIIB's Top Competitors

BIIB $362.44 (1.37%)
Current stock: BIIB
AMGN $159.73 (-0.05%)
Current stock: AMGN
GILD $107.12 (1.50%)
Current stock: GILD
$0.00 (0.00%)
Current stock: